GlaxoSmithKline Consumer Healthcare offers free nicotine lozenges for all certified pilots and air traffic controllers to help them safely quit smoking
In response to the announcement by the Federal Aviation Administration (FAA), Commit Lozenges now offered to pilots and air traffic controllers who are quitting smoking
With the Federal Aviation Administration's (FAA) recent announcement to remove a prescription anti-smoking pill from their approved list of safe medications for pilots, GSK Consumer Healthcare, an industry leader in smoking cessation, is offering one free 48 count of 2mg or 4mg Commit Cherry lozenges to all licensed commercial and private pilots who are interested in quitting smoking today, through June 30. It is important for pilots to understand that NRT has been the recommended aid for pilots to quit smoking since 1994, and that the FAA news in no way includes GSK's products, which are deemed safe and effective medicines to relieve nicotine withdrawal symptoms that arise during a quit attempt.
Corporate Social Responsibility News: GlaxoSmithKline Earns Environmental Stewardship Award from Nalco; Aspen Institute Opens 2011 Business and Society Case Competition for MBA Students.
This CSR Minute is brought to you by McKesson. For information about McKesson's corporate citizenship, please visit www.mckesson****/corporatecitizenship.
Watch this and other CSR Minute podcasts: *******3blmedia****/3bltv.
February 6, 2013 /3BL Media/ - GlaxoSmithKline plc [LSE/NYSE: GSK] today proceeded with the next stop in its national initiative to examine the barriers and identify opportunities to build healthier communities in the United States. The program, “A Conversation on Community Health” – which kicked off in late 2012 with forums in Philadelphia and St. Louis – is taking place today in Denver as the third in a series of events The Atlantic is hosting in US cities to explore what it means, and what it takes, to be a healthy community.
GSK is underwriting the events to uncover innovative, community-based collaborations with health organizations, public officials, advocates and citizens that will guide a new approach to improving health at the local level. Insights gained through the series of local discussions will help shape the future strategic direction for GSK’s community programs and local engagement in the US.
“At GSK, we realize that collaboration is a fundamental building block to ensuring patients have access to the opportunities and resources they need to live healthier lives and to ultimately achieving healthier communities and a healthier America,” said Deirdre Connelly, President, North America Pharmaceuticals at GlaxoSmithKline. “We heard in Philadelphia and St. Louis that there is a need to engage communities in a more meaningful way to uncover new ideas to improving their health. With the existing strong commitment from health organizations, and both leaders and members of the community to come together to drive positive change, Denver is an model city – and Colorado is an ideal state – for pursuing new partnerships and innovative approaches to improving the overall health of the community.”
In Denver, The Atlantic will convene an expert working summit of some of the region’s top minds in the fields of medicine, public health, academia, government, business and philanthropy to analyze the broader factors that influence health. The group will also share examples of approaches across the city and state that are effectively overcoming systemic barriers to better outcomes.
A town hall meeting immediately following the working summit will feature a keynote interview with Colorado Gov. John Hickenlooper. A panel discussion will include prominent speakers, such as Dr. David Goff, Dean, Colorado School of Public Health; Dr. Patricia Gabow, Former CEO, Denver Health and Hospital Authority; and Landri Taylor, President and CEO, Urban League of Metropolitan Denver.
“Denver has worked in an exceptional way to coordinate public safety net health care services that have enabled access to care and better outcomes for less money for the underserved in our community,” said Dr. Patricia Gabow, Former CEO, Denver Health and Hospital Authority. “We now have the opportunity to apply our learnings to community programs for children and young adults, ensuring that we successfully meet the unique educational, health and social challenges of the next generation of Denver citizens who represent the hope and future of our city.”
The town hall meeting, moderated by John Donvan, correspondent for ABC News, will challenge conventional thinking about what it means to be a healthy community and get participants to think more broadly about issues affecting their city and region. The meeting will feature innovative technology to integrate attendees into the on-stage conversation on community health to have a solutions-oriented conversation based on feedback from attendees representative of the broader Denver community.
Each group from the audience will use iPads powered by MtgWorksTM, an app that allows for the rapid collection of responses and the real-time synthesis of key themes, which will then be explored by the guest panel in a large discussion.
Additional information about “A Conversation on Community Health,” hosted by The Atlantic - The Denver town hall will be available via live stream from 10:45 am – 1 pm MT on Wednesday, February 6 at *******events.theatlantic****.
Over the course of the three city program, The Atlantic will be exploring the many facets of community health through an ongoing special report available at *******theatlantic****/special-report/health-nation.
Join the conversation on Twitter GSKUS or Atlantic_Live, #HealthyCommunity.
GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information go to us.gsk****, follow us on twitter****/GSKUS or visit our blog (www.morethanmedicine.us.gsk****/blog/).
Corporate Social Responsibility News: Allison & Partners Publishes Corporate Social Impact Marketing Snapshot; GlaxoSmithKline Joins World Anti-Doping Agency for London 2012 Olympic Campaign.
Watch this and other CSR Minute podcasts: *******3blmedia****/3bltv
Do more, feel better, live longer. GlaxoSmithKline ist ein weltweit führendes, forschungsorientiertes Gesundheitsunternehmen, das sich der Entwicklung innovativer Arzneimittel verschrieben hat. Unser Anspruch ist es, die Lebensqualität von Menschen zu verbessern, in dem wir ihnen ein aktives, längeres und gesünderes Leben ermöglichen. Weitere Informationen über GlaxoSmithKline finden Sie auf unserer Website www.glaxosmithkline.ch.
Everyone is looking for a nice save haven in these dark and turbulent times. And what could be safer than a pharmaceutical giant.
Perhaps one traditionally safe share has been oversold in recent times and might be looking good for a morsel of money.
As our broken health care system and escalating costs associated with chronic disease and health insurance continue to take center stage in this year's presidential campaigns, an innovative employer-based program is celebrating its third year of improving health and reducing costs for people with diabetes.
The Diabetes Ten City Challenge (DTCC), launched in 2005, is an employer-based diabetes self-management program conducted by the APhA Foundation with support from GlaxoSmithKline. Through the DTCC, participating employers establish a voluntary health benefit for employees, dependents and retirees with diabetes, and waive co-payments for diabetes medications and supplies if they work with a pharmacist "coach" to manage their condition. The DTCC is modeled after other highly successful APhA programs that have shown to improve overall health, reduce absenteeism, shorten hospital stays and reduce health care costs.
To view Multimedia News Release, go to *******www.prnewswire****/mnr/dtcc/35730/
Ob Millionen von Diabetikern oder Tausende Leukämie-Erkrankte: Weltweit kann vielen Pa-tienten mit biotechnologisch hergestellten Medikamenten geholfen werden. Die Forscher von GlaxoSmithKline sind weltweit neuen Therapiemöglichkeiten mit biopharmazeutisc
GSK & Save the Children
By Michael M, GSK Communications
Today, we announced an ambitious new partnership with Save the Children to save the lives of a million of the poorest children in the world.
While good progress has been made in recent years, almost seven million children die each year through lack of access to basic healthcare, vaccines or nutritious food. Through these and other initiatives, the partnership aims to help save the lives of one million children in the next five years. We're working together in a very different way--sharing expertise, resources, reach and influence to tackle some of the leading causes of childhood deaths.
GSK and Save the Children have been working together for eight years on a number of public health projects, including our initiative to reinvest 20% of the profits we make in the least-developed-countries in community programs to strengthen healthcare infrastructure, primarily through the training of community health workers. We've even sent a number of employees to work with them for extended assignments through our employee volunteer program called PULSE.
Ivy, who works in our Philadelphia office, recently returned from a PULSE assignment with Save the Children. Watch her describe why she is so excited about this new collaboration.
GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk****
Save the Children - Save the Children works in more than 120 countries and helps to save children's lives, fight for their rights and help them fulfil their potential. For more information visit: www.savethechildren*******
This is an essential part to success with a raw food diet, vegan diet, whole food diet or any other weight loss plan you're on...
You have to embrace failure.
I know it sounds weird, but you have to actually use failure to your advantage for your own success. I've seen it happen over and over again. So now it's time for it to work for you.
In this quick video, I show you how you can do it for your own success.
Check it out and take action today!
MadAboutOption High octane options fun with strategies and ideas based on Cramer's picks.
Starting today, smokers will no longer be scolded in a finger-waving, disapproving manner – but will actually hear something they wouldn’t expect from a smoking cessation brand.
To view Multimedia News Release go to, *******multivu.prnewswire****/mnr/nicorette/41512/
Leading, empowering, changing, giving... the contemporary culture of GSK attracts ambitious and caring talent.
*******www.weightlosssurgerychannel**** Directory Barry Levinson announced he will be tackling the nation’s obesity epidemic in a documentary currently in development. The film, however, is already raising criticism.